08 October 2018 – Grab Looking To Raise Another $1bn

Deals

Southeast Asian ride hailing platform Grab closed $2bn in funding just two months ago, but Reuters has reported that it’s looking to raise another $1bn, and that SoftBank is close to putting up half the funding.

SoftBank Vision Fund has also initiated talks to invest $500m in China-based online educational assistance platform Zuoyebang.

Traveloka, an Indonesian company that has grown into a leading holiday and travel services booking platform for Southeast Asia, is in talks with unnamed investors to raise $400m.

Elsewhere in Asia, SoftBank is reportedly in talks to invest between $200m and $250m in India-based Delhivery, one of several companies that have sprung up to feed the rapidly expanding e-commerce sector.

Enterprise cybersecurity software provider Tanium has secured $200m in a round led by Wellington Management that valued it at $6.5bn pre-money. Tanium, whose investors include Citi Ventures, has now raised about $780m altogether, and has amped up its valuation by some $1.5bn in just five months, the company having raised $175m from TPG Growth in a May round that valued it at $5bn.

Tencent and KKR’s KKR Asian Fund III have agreed to lead a $175m investment in Voyager Innovations, a fintech spinoff from telecommunications firm PLDT.

Fast fashion retailer Miniso was only founded in 2013 but has been growing at a rocket-like pace, currently standing at some 3,000 branches worldwide. Now Tencent is getting in on the act, joining Hillhouse Capital to provide $146m in funding for the company.

Education app developer Byju’s is now valued at $2bn following a $100m investment by General Atlantic India. Byju’s has raised a total of $344m from investors including Times Internet and Tencent, but the round is perhaps notable for not including SoftBank, which was said to be in talks with the company a couple of months back.

Call centre software provider Talkdesk closed a $21m series A round backed by Salesforce three years ago, but has taken a bug step forward with a $100m series B round that valued it at more than $1bn.

JHL Biotech has raised an undisclosed sum from investors including Sanoft at a $750m valuation and will put the cash toward further development of its biosimilar cancer therapies.

Drawbridge Health, a US-based medical diagnostics spinout of industrial conglomerate General Electric (GE), received an undisclosed amount of funding yesterday from Kyoto University’s venturing arm Innovation Capital (Kyoto-iCap).

Funds

Biopharmaceuticals-focused venture firm Forbion Capital Partners has closed its latest fund at $415m, a 44% upgrade on its initial target. The fund’s LPs include insurers ASR Insurances, KLP, the EU-backed European Investment Fund and the German government-owned bank KfW.

Excell Partners, a VC fund affiliated to University of Rochester, is to manage a $25m vehicle intended to spur tech activity around Rochester in upstate New York. The vehicle, dubbed Finger Lakes Forward Venture Capital (FLX) Fund, will be managed by Excell’s Technology Ventures division and funded by the New York State government.

Exits

Funding Circle has gone public in London, in a $576m initial public offering that included $184m of share sales by the online lending platform’s shareholders.

Guardant Health had a health first day as a public company, floating above its range to raise almost $238m in its IPO before seeing its share price rise by 69%.

SurveyMonkey has raised less but had a more successful IPO, floating above its range last week to raise an initial $180m.

Sutro Biopharma, a US-based cancer drug developer based on research at Stanford University and backed by pharmaceutical firms Amgen, Celgene, Eli Lilly and Merck & Co, raised $85m in its initial public offering.

NGM Biopharmaceuticals has filed to raise up to $75m in an initial public offering that will give Merck & Co and Takeda the chance to exit.

On GGV, French solar firm Neoen is aiming for a market capitalisation of €1.5bn ($1.7bn) in an initial public offering (IPO) on the Paris stock exchange.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

27 March 2017 – MuleSoft’s Shares Soar Following $221m IPO and Much More

MuleSoft raised $221m in its IPO on Friday, only to see its share price soar to almost twice the mid-point of its range. The offering is good news for the IPO market generally but also for enterprise software providers looking to go public.

Deals

Flipkart has raised $1bn in funding from investors including Tencent, Microsoft and eBay and is reportedly seeking up to $1bn more in the next few months.

Tencent has led a $350m round for Kuaishou, which is also backed by Baidu, and both the corporates will help the company enhance user experience of its app, which boasts 50 million daily active users.

SoftBank has invested $300m in working space provider WeWork at a $17bn valuation and reportedly expects to add another $2.7bn through Vision Fund.

Sutro Biopharma spinout SutroVax has raised $64m, $60m of that coming from a series B round backed by Roche Venture Fund, and will use the funds to advance its development of a conjugate vaccine for pneumococcal disease.

Haoeyou has raised $40m for its medical tourism platform, which allows Chinese patients to access consultancies from US-based doctors through video conferencing, and to travel between countries for treatment.

Legend Capital is among the investors that have provided $39m in series B funding for Suzhou Ribo Life Science, a Chinese company developing RNA therapeutics to treat diseases such as hepatitis B, hyperlipidaemia and liver cancer.

Genome editing technology startup eGenesis has raised $38m in a series A round backed by healthcare services firm Heritage Provider Network and biotech property developer Alexandria Real Estate Equities.

Autonomous car tech continues to roll on, with Autotalks, a developer of chipsets that will be used in vehicle-to-vehicle communication, raising $30m in series D funding.

GlaxoSmithKline and Johnson & Johnson have contributed to a $30m series B round for Pulmocide, a developer of therapies to combat diseases caused by respiratory syncytial virus.

Funds

Aflac has joined the numerous insurance providers that have established strategic investment arms over the past two years, forming a subsidiary called Aflac Corporate Ventures, in which it plans to invest $100m over the next three years.

Kabbage, the operator of an online lending platform for small businesses, is said to be in talks with investment firms to raise “a few hundred million dollars” that will be put toward acquisitions.

The European Fund for Strategic Investments (Efsi), also known as the Juncker Plan, is now set to trigger more than €177bn ($190bn) in total investments, figures released following a meeting of the European Investment Bank’s board of directors show.

Exits

Amazon has beefed up its international e-commerce holdings, entering the Middle East through a $650m acquisition of local market leader Souq.com that provided Naspers and Jabbar Internet Group with exits.

Alibaba paid an undisclosed sum for a 32% stake in Damai.cn in 2014 and has now finished the job, acquiring the rest of the online ticketing platform.

Netshoes, a Brazil-based sports e-commerce company backed by Singapore government-owned GIC and Temasek as well as the International Finance Corporation, has filed for an initial public offering on the New York Stock Exchange that could bring in $100m in proceeds.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0